Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Clinical trial NCT03012321 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03012321
Sponsor: Northwestern University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-Resistant Abnormal DNA Repair Metastatic Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2017-01-12
Primary completion: 2023-10-21
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.